Sharps Technology : Working to Close on, Enhanced Asset Purchase Agreement & Accompanying Five-Year, $200 Mln Syringe Sales Agreement With Nephron
夏普科技:努力完成增強資產購買協議並隨之簽署五年2億美元的注射器銷售協議與Nephron。
Sharps Technology : Working to Close on, Enhanced Asset Purchase Agreement & Accompanying Five-Year, $200 Mln Syringe Sales Agreement With Nephron
夏普科技:努力完成增強資產購買協議並隨之簽署五年2億美元的注射器銷售協議與Nephron。
譯文內容由第三人軟體翻譯。